August 06, 2013
2 min read
Save

Blood cultures ineffective for management of uncomplicated SSTIs

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Blood cultures were not efficient in providing management for children diagnosed with uncomplicated skin and soft tissue infections, according to recent study findings published in Pediatrics.

Perspective from C. Buddy Creech, MD, MPH

“More than 90% of children admitted to the hospital for [skin and soft tissue infections] undergo laboratory investigations, including blood cultures,” researchers wrote. “However, our study found that blood cultures are positive in <1% of patients with uncomplicated [skin and soft tissue infections] and so do not improve patient management.”

The study included medical records for children aged 0 to 18 years admitted to The Children’s Hospital of Oklahoma following diagnosis of a skin and soft tissue infection (SSTI) in the ED. Ninety-eight patients had a complicated SSTI (cSSTI) and 482 had SSTIs.

Researchers found that none of the participants with SSTI had a positive blood culture compared with 12.5% of the cSSTI group.

Participants with an uncomplicated SSTI had a 3.2 days mean length of hospital stay compared with participants with cSSTIs at 6.6 days. Also, participants with an uncomplicated SSTI for which a blood culture was performed had 0.91 days longer hospital stay compared with those without a blood culture (95% CI, 0.026-1.8 days).

“Blood cultures are not useful in the management of uncomplicated SSTI, and additionally may results in longer hospital stays,” Jay R. Malone, MD, MS, of the University of Oklahoma told Infectious Diseases in Children. “Proper identification of complicated cases is important because of the high risk of bacteremia in that population.”

Disclosure: The researchers report no relevant financial disclosures.